Literature DB >> 12671045

Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Taichi Sakaguchi1, Shi Fang Yan, Shi Du Yan, Dmitri Belov, Ling Ling Rong, Monica Sousa, Martin Andrassy, Steven P Marso, Stephan Duda, Bernd Arnold, Birgit Liliensiek, Peter P Nawroth, David M Stern, Ann Marie Schmidt, Yoshifumi Naka.   

Abstract

Cellular proliferation, migration, and expression of extracellular matrix proteins and MMPs contribute to neointimal formation upon vascular injury. Wild-type mice undergoing arterial endothelial denudation displayed striking upregulation of receptor for advanced glycation end products (RAGE) in the injured vessel, particularly in activated smooth muscle cells of the expanding neointima. In parallel, two of RAGE's signal transducing ligands, advanced glycation end products (AGEs) and S100/calgranulins, demonstrated increased deposition/expression in the injured vessel wall. Blockade of RAGE, employing soluble truncated receptor or antibodies, or in homozygous RAGE null mice, resulted in significantly decreased neointimal expansion after arterial injury and decreased smooth muscle cell proliferation, migration, and expression of extracellular matrix proteins. A critical role for smooth muscle cell RAGE signaling was demonstrated in mice bearing a transgene encoding a RAGE cytosolic tail-deletion mutant, specifically in smooth muscle cells, driven by the SM22alpha promoter. Upon arterial injury, neointimal expansion was strikingly suppressed compared with that observed in wild-type littermates. Taken together, these data highlight key roles for RAGE in modulating smooth muscle cell properties after injury and suggest that RAGE is a logical target for suppression of untoward neointimal expansion consequent to arterial injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671045      PMCID: PMC152587          DOI: 10.1172/JCI17115

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

3.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 4.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

5.  IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8.

Authors:  K Xu; C L Geczy
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

6.  Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury.

Authors:  E D Reis; M Roqué; C Cordon-Cardo; M Drobnjak; V Fuster; J J Badimon
Journal:  J Vasc Surg       Date:  2000-11       Impact factor: 4.268

7.  Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease.

Authors:  K Yamamoto; R Morishita; N Tomita; T Shimozato; H Nakagami; A Kikuchi; M Aoki; J Higaki; Y Kaneda; T Ogihara
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

8.  Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury.

Authors:  Y Seki; H Kai; R Shibata; T Nagata; H Yasukawa; A Yoshimura; T Imaizumi
Journal:  Circ Res       Date:  2000-07-07       Impact factor: 17.367

9.  Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model.

Authors:  J T Tai; E E Brooks; S Liang; R Somogyi; J D Rosete; R M Lawn; D Shiffman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-10       Impact factor: 8.311

10.  Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries.

Authors:  Y Furukawa; A Matsumori; N Ohashi; T Shioi; K Ono; A Harada; K Matsushima; S Sasayama
Journal:  Circ Res       Date:  1999-02-19       Impact factor: 17.367

View more
  133 in total

1.  Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.

Authors:  Nicola Origlia; Camilla Bonadonna; Alfredo Rosellini; Elena Leznik; Ottavio Arancio; Shirley Shidu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

2.  S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.

Authors:  Ling Yan; Liby Mathew; Bijoy Chellan; Brandon Gardner; Judy Earley; Tipu S Puri; Marion A Hofmann Bowman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

3.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

4.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine.

Authors:  Mohan Satish; Palanikumar Gunasekar; Juan A Asensio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2020-08-01       Impact factor: 3.396

5.  Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells.

Authors:  C B Renard; B Askari; L A Suzuki; F Kramer; K E Bornfeldt
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

6.  Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.

Authors:  Li Meng; Jehyun Park; Qiangjun Cai; Linda Lanting; Marpadga A Reddy; Rama Natarajan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

7.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

8.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

9.  RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction.

Authors:  Kazuhiro Takuma; Fang Fang; Wensheng Zhang; Shiqiang Yan; Emiko Fukuzaki; Heng Du; Alexander Sosunov; Guy McKhann; Yoko Funatsu; Noritaka Nakamichi; Taku Nagai; Hiroyuki Mizoguchi; Daisuke Ibi; Osamu Hori; Satoshi Ogawa; David M Stern; Kiyofumi Yamada; Shirley Shidu Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

Review 10.  RAGE: a novel target for drug intervention in diabetic vascular disease.

Authors:  Barry I Hudson; Ann Marie Schmidt
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.